Advertisement
Screener

Oncotelic Therapeutics, Inc. (OTLC) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

1.9 / 5 stars · 15/40 Roast Me

Oncotelic Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

Oncotelic Therapeutics, Inc. (OTLC) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 88.00% for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-10.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2019-04-10

  • Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2017-03-31 was 89.00%, a 0.00% change year-over-year.
  • Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2016-03-31 was 89.00%, a 5.82% decline year-over-year.
  • Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2015-03-31 was 94.50%, a 2.58% decline year-over-year.
  • Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2014-03-31 was 97.00%, a 3.96% decline year-over-year.
  • Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2018 was 88.00%, a 0.00% change from fiscal 2017.
  • Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2017 was 88.00%, a 0.00% change from fiscal 2016.
  • Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2016 was 88.00%, a 4.35% decline from fiscal 2015.
  • Oncotelic Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2015 was 92.00%, a 7.07% decline from fiscal 2014.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month
2018-12-3188.00%
10-K · filed 2019-04-10
2018-09-3088.00%
10-Q · filed 2018-11-14
2018-06-3088.00%
10-Q · filed 2018-08-14
2017-12-3188.00%
10-K · filed 2019-04-10
2017-09-3088.00%
10-Q · filed 2018-11-14
2017-06-3088.00%
10-Q · filed 2018-08-14
2017-03-3189.00%
10-Q · filed 2018-05-14
2016-12-3188.00%
10-K · filed 2018-04-17
2016-09-3089.00%
10-Q · filed 2017-11-14
2016-06-3089.00%
10-Q · filed 2017-08-02
2016-03-3189.00%
10-Q · filed 2017-05-08
88.99%
10-Q · filed 2016-05-06
2015-12-3192.00%
10-K · filed 2017-03-30
2015-09-3092.00%
10-Q · filed 2016-11-14
2015-06-3092.00%
10-Q · filed 2016-08-02
2015-03-3194.50%
10-Q · filed 2016-05-06
2014-12-3199.00%
10-K · filed 2016-03-25
2014-09-30101.00%
10-Q · filed 2015-11-12
2014-06-30101.00%
10-Q · filed 2015-08-06
2014-03-3197.00%
10-Q · filed 2014-05-08
2013-12-31100.00%
10-K · filed 2015-03-30
2013-09-30100.00%
10-Q · filed 2013-11-13
2013-06-30101.00%
10-Q/A · filed 2013-10-18
2013-03-31101.00%
10-Q · filed 2013-05-09
2012-12-31102.00%
10-K · filed 2015-03-30
2012-09-30102.00%
10-Q · filed 2012-11-09
2012-06-30102.00%
10-Q · filed 2012-08-13
2011-12-31112.00%
10-K · filed 2014-03-20
2010-12-3170.00%
10-K · filed 2013-03-15